G. Yasuda et al., CHARACTERIZATION OF BUNAZOSIN-SENSITIVE ALPHA(1)-ADRENOCEPTORS IN HUMAN RENAL MEDULLA, Journal of cardiovascular pharmacology, 30(2), 1997, pp. 163-168
We studied the characteristics of bunazosin-sensitive alpha(1)-adrenoc
eptors in human renal medullae by using renal-clearance studies and ra
dioligand-binding assay. In 12 patients with hypertension, renal-clear
ance studies demonstrated that bunazosin significantly increased renal
blood flow from 683 +/- 82 (SD) to 829 +/- 103 ml/min (p < 0.05) and
decreased renal vascular resistance from 0.18 +/- 0.02 to 0.14 +/- 0.0
2 mm Hg/(ml/min) (p < 0.05), but that prazosin had little effect on re
nal function. In a radioligand-binding assay, specific, saturable, and
stereoselective [H-3]bunazosin binding, with a single class of bindin
g sites (K-d = 2.7 +/- 1.4 nM; B-max = 44 +/- 16 fmol/mg protein; n =
11) was detected in membrane prepara tions of human renal medullae. Th
e rank order of potency of antagonists that inhibited [H-3]bunazosin-b
inding was bunazosin (K-i in rM = 49) > prazosin (57) > yohimbine (3,9
00) > propranolol (29,000), and that of agonists, I-norepinephrine (7,
400) > I-epinephrine (19,000) > d-norepinephrine (71,000). The competi
tion curves fit a one-site model. These findings suggest that bunazosi
n-sensitive alpha(1)-adrenoceptors exist in human renal medullae and p
articipate in the regulation of renal hemodynamics.